New Study Confirms: specific Bioactive Collagen Peptides® reduce knee joint discomfort in young physically active adults

The randomized controlled trial rigorously showed the benefits of GELITA’s FORTIGEL^® in reducing the intensity of knee joint pain during activity, in healthy men and women.

Dr. Stephan Hausmanns, GELITA’s Vice President for Health & Nutrition, welcomes the new addition to the portfolio of studies: “FORTIGEL^® is the most clinically-studied Bioactive Collagen Peptides^®, for 30 years. Over 20 studies, involving more than 2,500 participants, contributed to develop FORTIGEL^® and prove the product’s positive effects to joint health”, he explains. “So far, no other collagen peptide solution on the market has been able to offer an alternative to FORTIGEL^®, backed by science”, concludes Stephan.

Recognizing the uniqueness of the product, Zdzieblik et al. (2021) stated in the study that the effects measured are valid only for FORTIGEL^®, the specific BCP^® used in the study, and cannot be readily applicable to other collagen products.

Download the complete Study now!